NCT03919669View on ClinicalTrials.gov

A Longitudinal Evaluation of a Radiotracer for Use in Tau Tracking

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

April 2, 2019

Primary Completion Date

May 19, 2022

Study Completion Date

May 19, 2022

Conditions
Alzheimer DiseaseMild Cognitive Impairment
Interventions
DRUG

All Subjects

All subjects will be given the experimental tau PET radioligand \[18F\]MK-6240

Trial Locations (1)

53792

University of Wisconsin-Madison, Madison

Sponsors
All Listed Sponsors
collaborator

Cerveau Technologies, Inc.

INDUSTRY

lead

University of Wisconsin, Madison

OTHER